Important note: Information in this article was accurate in March 2008. The state of the art may have changed since the publication date.
HIV Treat Bull - 2008 March-April;9(3/4):
This issue of HTB continues our coverage of the 15th Conference on Retroviruses and Opportunistic Infections with reports on antiretrovirals, treatment strategies, pregnancy and PMTCT, and hepatitis coinfection.
CROI is one of best resourced conferences for online access to presentations and abstract, and we hope these report will encourage you to view the originals online.
Futher reports will follow in the next issue.
STOP PRESS: i-Base funding withdrawn: urgent request for letters of support
As this issue of HTB went to press we learned that the London Health Commissioners have withdrawn funding for all i-Base projects.
For the last two years we have received £50k (just under 20% of our annual budget) towards the treatment phoneline and information services, adherence support publications (the BHIVA-recommended treatment passport) and treatment workshops.
Public funding stabilised the project sufficiently to continue to provide HIV Treatment Bulletin and the five i-Base treatment guides free to all individuals and clinics, and to run additional treatment workshops with community groups.
In retendering for services the London Commissioners declined to tender for any existing project and refuses to contribute towards the costs of any i-Base services...
No publications, no treatment workshops, no advocacy training, no phoneline support, no email services, no online Q&A services, no translations of treatment publications, no website.
The commissioners think that no patients or clinics in London want or need these services.
We think this is unfair and is not reflective of the needs of London patients and clinics.
If you use or have used i-Base services as a London patient or clinic, please email letters of support to:
ray.appleby@kc-pct.nhs.uk
hong.tan@londonscg.nhs.uk
It would help us if you could copy any correspondence to:
simon.collins@i-Base.org.uk
i-Base employs three full-time and four part-time staff for all our projects. Five of the seven staff are HIV-positive. The funding decision, for which we are told there is no appeal, threatens these posts and the services we provide.
Thank you for your support...
2008-03-10
IB080903-01
©2008. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.